Рет қаралды 4,613
The biotech industry saw reduced IPOs and investment in 2023. Is there reason for optimism? Noubar Afeyan, founder and chief executive officer of Flagship Pioneering, discusses innovations and trends in biotech that drive his 'paranoid optimism' in the industry.
#Biotechnology #Moderna #WSJ